Standard Biotools (LAB) Shares Outstanding (2010 - 2026)
Standard Biotools (LAB) posted quarterly Shares Outstanding (Entity) of $408.7 million for Q1 2026, up 2.78% year-over-year from $397.7 million in Q1 2025, and up 0.93% quarter-over-quarter from $405.0 million in Q4 2025.
Standard Biotools (LAB) Shares Outstanding (2010 - 2026) Analysis & Trends
Standard Biotools (LAB) has reported Shares Outstanding (Entity) for 17 consecutive years, with $408.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 2.78% year-over-year to $408.7 million; the TTM figure through Mar 2026 stood at $408.7 million (up 2.78% YoY), while the FY2025 annual figure was $405.0 million, up 2.23% from the prior year.
- Shares Outstanding (Entity) rose to $408.7 million in Q1 2026 per LAB's latest filing, from $405.0 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $408.7 million in Q1 2026 and bottomed at $77.2 million in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $242.8 million across 5 years, with a median of $294.1 million in 2024.
- Annual changes were most pronounced in 2024 — Shares Outstanding (Entity) soared 375.24% — and 2025, when it grew 2.23%.
- Standard Biotools' Shares Outstanding (Entity) stood at $79.9 million in 2022, then rose by 4.33% to $83.4 million in 2023, then jumped by 375.16% to $396.1 million in 2024, then gained by 2.23% to $405.0 million in 2025, then advanced by 0.93% to $408.7 million in 2026.
- Business Quant data shows LAB's Shares Outstanding (Entity) at $408.7 million in Q1 2026, $405.0 million in Q4 2025, and $402.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.08 Bn | 194.48 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 129.56 Bn | 126.09 Bn | 4.50 Bn | 383.50 Mn |
| 3 | Medtronic | 119.95 Bn | 110.73 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 73.85 Bn | 73.31 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 52.69 Bn | 48.44 Bn | 1.35 Bn | 576.40 Mn |
| 6 | Dexcom | 34.55 Bn | 32.60 Bn | 830.00 Mn | 382.20 Mn |
| 7 | GE HealthCare Technologies | 34.11 Bn | 32.00 Bn | 2.18 Bn | 453.00 Mn |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn | 955.57 Mn |
| 9 | Steris | 23.22 Bn | 22.73 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Standard Biotools | 256.97 Mn | -219.75 Mn | 10.54 Mn | 390.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 390.88 Mn |
| Mar 31, 2026 | 388.20 Mn |
| Dec 31, 2025 | 381.62 Mn |
| Sep 30, 2025 | 382.63 Mn |
| Jun 30, 2025 | 380.50 Mn |
| Mar 31, 2025 | 378.23 Mn |
| Dec 31, 2024 | 353.25 Mn |
| Sep 30, 2024 | 371.54 Mn |
| Jun 30, 2024 | 372.33 Mn |
| Mar 31, 2024 | 294.13 Mn |
| Dec 31, 2023 | 79.16 Mn |
| Sep 30, 2023 | 79.15 Mn |
| Jun 30, 2023 | 78.67 Mn |
| Mar 31, 2023 | 79.08 Mn |
| Dec 31, 2022 | 78.31 Mn |
| Sep 30, 2022 | 78.90 Mn |
| Jun 30, 2022 | 77.82 Mn |
| Mar 31, 2022 | 77.03 Mn |
| Dec 31, 2021 | 75.79 Mn |
| Sep 30, 2021 | 76.30 Mn |